SCHEMBL6396397

SCHEMBL6396397

COc1ccc(C(=O)C(CP=O)C(=O)c2c(C)cccc2C)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.43
NPC1 O15118 4/20 0.42
RAB9A P51151 5/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 4/20 0.42
ABCG2 Q9UNQ0 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TNFRSF1A P19438 1/20 0.41
PKM P14618 2/20 0.40
HTT P42858 2/20 0.40
HPGD P15428 2/20 0.40
GAA P10253 1/20 0.40
LMNA P02545 2/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5993302 0.88 TP53 (0.46) TP53NPC1RAB9AMAPTMEN1
SCHEMBL152304 0.79 L3MBTL1 (0.36) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL5994591 0.77 CYP3A4 (0.39) MAPTMEN1KMT2AABCG2SMN1; SMN2
SCHEMBL5997921 0.76 KMT2A (0.35) TP53MAPTMEN1KMT2AALDH1A1
SCHEMBL5994253 0.74 MAPT (0.46) TP53NPC1RAB9AMAPTMEN1
SCHEMBL6399267 0.74 CYP3A4 (0.37) KMT2AABCG2SMN1; SMN2HPGDLMNA
SCHEMBL5994805 0.72 ALDH1A1 (0.35) KMT2AALDH1A1SMN1; SMN2PKMGAA
SCHEMBL6396405 0.71 NPC1 (0.44) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL5996413 0.71 TP53 (0.50) TP53NPC1RAB9AMAPTMEN1
SCHEMBL5994244 0.70 ALDH1A1 (0.46) TP53NPC1RAB9AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6969733-B2 Photoinitiators CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-11-29 US disclosed
US-20030139485-A1 Photoinitiators WOLF JEAN-PIERRE (CH) 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139485-A1 Photoinitiators DHCR24, NR1I3, CBR1 TP53 4142/4885NPC1 850/4885RAB9A 3300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.